Latest News & Features
Americas
Hedge fund manager Kyle Bass has returned almost $700 million to investors that backed his inter partes review challenges, but has vowed to continue challenging pharmaceutical patents after being given the green light to tackle another. 24 February 2016
Americas
The US Court of Appeals for the First Circuit has revived claims that pay-for-delay settlements involving pharmaceutical company Warner Chilcott may be in breach of competition law, despite the deals not including cash payments. 23 February 2016
Americas
AstraZeneca has sued Innopharma over its attempt to market a generic version of breast cancer treatment drug Faslodex. 22 February 2016
Big Pharma
The English High Court has rejected Janssen Sciences’ request for a stay in its patent infringement and invalidity dispute with Eli Lilly. 19 February 2016
Americas
The US Federal Trade Commission has waded into a competition dispute at the US Court of Appeals for the Federal Circuit centring on ‘reverse payment’ settlements. 18 February 2016
Americas
Sandoz has petitioned the US Supreme Court to review the US Court of Appeals for the Federal Circuit’s ruling in the ‘patent dance’ dispute. 17 February 2016
Americas
Galderma Laboratories has successfully avoided three inter partes review petitions being instituted against a patent covering its Oracea (doxycycline, USP) drug, used to treat skin condition rosacea. 17 February 2016
Americas
Law firm Reed Smith has expanded its intellectual property, information and innovation group by hiring Lisa Chiarini as a partner in New York. 17 February 2016
Americas
Accord Healthcare’s attempt to market a generic version of Pfizer’s Tygacil has hit a brick wall after it was accused of infringing three patents. 16 February 2016
Americas
Law firm Steptoe & Johnson has hired Ying Li as a partner in the firm’s intellectual property group in New York. 16 February 2016